Alnylam Pharmaceuticals
ALNY
#622
Rank
โ‚น2.749 T
Marketcap
โ‚น21,315
Share price
-1.16%
Change (1 day)
35.90%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company